KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Gross Profit: 2017-2025

Historic Gross Profit for Elanco Animal Health (ELAN) over the last 8 years, with Sep 2025 value amounting to $607.0 million.

  • Elanco Animal Health's Gross Profit rose 12.83% to $607.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 billion, marking a year-over-year increase of 3.57%. This contributed to the annual value of $2.4 billion for FY2024, which is 2.01% down from last year.
  • According to the latest figures from Q3 2025, Elanco Animal Health's Gross Profit is $607.0 million, which was down 14.87% from $713.0 million recorded in Q2 2025.
  • In the past 5 years, Elanco Animal Health's Gross Profit registered a high of $763.0 million during Q1 2023, and its lowest value of $519.0 million during Q4 2023.
  • Moreover, its 3-year median value for Gross Profit was $623.0 million (2023), whereas its average is $629.6 million.
  • Per our database at Business Quant, Elanco Animal Health's Gross Profit surged by 150.69% in 2021 and then declined by 11.92% in 2022.
  • Over the past 5 years, Elanco Animal Health's Gross Profit (Quarterly) stood at $602.0 million in 2021, then fell by 10.80% to $537.0 million in 2022, then declined by 3.35% to $519.0 million in 2023, then remained steady at $519.0 million in 2024, then increased by 12.83% to $607.0 million in 2025.
  • Its Gross Profit stands at $607.0 million for Q3 2025, versus $713.0 million for Q2 2025 and $684.0 million for Q1 2025.